Julia A. Townsend

Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model

Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update

Discovery of Di- and Trihaloacetamides as Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity

Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease